Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-29T00:05:48.708Z Has data issue: false hasContentIssue false

Brain Respiration and Glycolysis in Cardiazol Convulsions

Published online by Cambridge University Press:  08 February 2018

Leslie Dundonald MacLeod
Affiliation:
Burden Neurological Institute, Stapleton, Bristol
Max Reiss
Affiliation:
Burden Neurological Institute, Stapleton, Bristol

Extract

Since Hildebrandt (1926) described the convulsant effect of cardiazol injection, several studies have been carried out on the mechanism of such convulsions. Zung and Tremonti (1931) suggested a direct action on the respiratory centre when cardiazol is used as a stimulant; Kerr and Antaki (1937) found no effect on brain glycogen or phosphocreatine in cardiazol-induced convulsions; Hashimoto (1937) found differences in distribution of calcium and potassium ions in the central nervous system after cardiazol. Goodwin and Lloyd (1938) recorded a direct effect on brain potential changes as shown on oscillographic records. Leibel and Hall (1938) found a large (75 per cent.) diminution of cerebral blood-flow at the onset of cardiazol convulsions. Weigand (1938) found no effect on liver glycogen or vitamin A content, reducing power of suprarenal cortex or blood picture. Denyssen and Watterson (1938) and Watterson and Macdonald (1939) attribute the convulsions to action on the vasomotor centre and note the action of vasodilator drugs in inhibiting convulsions. Wortis (1938) quoted by Quastel (1939) found no effect on brain respiration.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1940 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Denyssen, and Watterson, (1938), Journ. Ment. Sci., 84, 1002.Google Scholar
Dixon, (1934), Manometric Methods. Cambridge University Press.Google Scholar
Goodwin, and Lloyd, (1938), Proc. Soc. expt. Biol, and Med., 38, 897.CrossRefGoogle Scholar
Hashimoto, (1939), Japan Journ. Med. Sci., 10, 183.Google Scholar
Hildebrandt, (1926), Journ. exper. Path. u. Pharm., 116, 100.Google Scholar
Kerr, and Antaki, (1937), Journ. Biol. Chem., 122, 49.CrossRefGoogle Scholar
Labes, Wedell and Soehring, (1937), Arch. exper. Path. u. Pharm., 185, 379.Google Scholar
Leibel, and Hall, (1938), Proc. Soc. exper. Biol. and Med., 38, 894.Google Scholar
Quastkl, (1939), Ann. Rev. Biochem., 8, 444.Google Scholar
Watterson, and Macdonald, (1939), Journ. Ment. Sci., 85, 392.CrossRefGoogle Scholar
Weigand, (1938), Z. ges. exper. Med., 103, 775.Google Scholar
Wortis, (1938), New York State Journ. Med., 38, 1,015.Google Scholar
Zung, and Tremonti, (1931), Arch, intern. Pharmacodynamie, 41 1.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.